CARBOGEN AMCIS SAS

Carbogen AMCIS SAS, part of the Carbogen AMCIS group, is a leading company that offers a comprehensive range of services for the development and for contract manufacturing of sterile lyophilized and liquid dosage forms for New Molecular Entities (NMEs) for preclinical and clinical studies. Originally located in Riom, Carbogen AMCIS inaugurated a new facility in the Biopôle Clermont-Limagne at the beginning of 2023. This new facility is equipped with 2 state-of-the-art production lines, unique in Europe, that will accommodate the production of parenteral drug products in liquid and lyophilized forms in vials. Carbogen AMCIS can supply its customers with clinical batches for phase III clinical trials and small-scale for commercial.